• MF News
  • Market News
  • IPO News


Tejas Khoday An investor has to be patient and undertake the necessary research before zeroing in on the schemes to invest – either lumpsum or via SIP.
Sun, 02 Aug 2020 08:46:17 +0530


Interest in ESG investing is rising, but identifying companies that meet the parameters is difficult We are still in the early days of ESG investing in India. But interest in the space has definitely been increasing and mutual fund companies have realized that.
Sat, 01 Aug 2020 14:37:34 +0530


Amandeep Chopra Investors have taken comfort from the government's focus on inflation. The long-term yields have come off, said Amandeep Chopra of UTI MF, adding that the theme has to be sustained for a longer time.
Thu, 23 Jun 2016 10:35:08 +0530


Mindspace Business Parks REIT IPO subscribed 13 times on final day Mindspace REIT public issue consists of a fresh issue of Rs 1,000 crore and an offer for sale of Rs 3,500 crore.
Wed, 29 Jul 2020 18:08:23 +0530


Mindspace Business Parks REIT IPO fully subscribed on second day The issue will close on July 29 and the bids can be made for minimum 200 units and in multiples of 200 units thereafter.
Tue, 28 Jul 2020 19:23:01 +0530


Mindspace Business Parks REIT IPO subscribed 38% on Day 1 From an investor standpoint, the REIT product is a must-have in any portfolio, said Sharad Mittal, CEO at Motilal Oswal Real Estate Fund.
Mon, 27 Jul 2020 19:37:07 +0530


IIFL Securities recommends subscribing to Mindspace Business Parks REIT IPO; here#39;s why IIFL Securities has recommended the issue for investors seeking returns similar to debt asset class.
Sun, 26 Jul 2020 15:56:10 +0530


Mindspace Business Parks REIT IPO opens on July 27; here are 10 things you should know Mindspace has so far raised Rs 2,643.74 crore from strategic and anchor investors, which is 58.74 percent of the total issue size of Rs 4,500 crore.
Sat, 25 Jul 2020 15:02:45 +0530


3 Point Analysis | Rossari Biotech#39;s stellar listing: What should investors do now? The stock opened with a premium of Rs 245, or 58 percent, on the BSE against its issue price of Rs 425 per share, and rose to Rs 710 intraday, i.e. 67.1 percent higher
Thu, 23 Jul 2020 21:20:14 +0530


Rossari Biotech debuts at Rs 670 with 58% premium over IPO price The listing premium was much higher than the grey market premium (of around Rs 160-180 per share) as well as analysts#39; expectations of Rs 130-175 per share.
Thu, 23 Jul 2020 10:03:35 +0530


Subscribe to Rossari Biotech: Ajcon Research Ajcon Research Rossari Biotech Started in CY03 as “Rossari Lab tech”, a partnership firm, Rossari was converted to Company in CY09 by Mr. Edward Menezes and Mr. Sunil Chari.
Fri, 17 Jul 2020 15:09:34 +0530


Yes Bank FPO subscribed 95% so far, QIB remains strong on final day The maximum bids received at lower end of price band of Rs 12-13 per share. In fact, the anchor book, through which the lender had received Rs 4,098 crore, was also subscribed at Rs 12 per share.
Fri, 17 Jul 2020 15:06:55 +0530


Rossari Biotech#39;s Rs 496-crore IPO subscribed 79 times so far on last day The public issue consists of a fresh issue of Rs 50 crore and an offer for sale of 1.05 crore equity shares by its promoters Edward Menezes and Sunil Chari.
Wed, 15 Jul 2020 11:58:45 +0530


Rossari Biotech IPO subscribed 3 times on Day 2 amid retail, QIB interest In past 3 years (FY17-FY20), company has delivered stupendous growth on revenue, EBITDA and net profit level, which grew at a CAGR of 42 percent, 57 percent and 60 percent respectively.
Tue, 14 Jul 2020 14:40:37 +0530


Subscribe to Rossari Biotech: Emkay Global Financial Emkay Global Financial Rossari Biotech is planning to raise ~Rs4.95bn through a mix of fresh issue (Rs500mn, 1.17mn shares) combined with Offer for Sale (OFS) route (~Rs4.45bn, 10.5mn shares), to the public.
Mon, 13 Jul 2020 18:07:11 +0530


Subscribe to Rossari Biotech: Motilal Oswal Motilal Oswal Hence, investors can Subscribe the IPO from a long term perspective.
Mon, 13 Jul 2020 17:47:49 +0530


Subscribe to Rossari Biotech: Ventura Securities Ventura Securities Rossari Biotech (Rossari) is one of the leading specialty chemicals manufacturing company in India, catering to various customer needs across FMCG, apparel, and poultry and animal feed industries.
Mon, 13 Jul 2020 17:31:48 +0530


Subscribe to Rossari Biotech: Mehta Equities Mehta Equities has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe#39;#39; the IPO in its research report as on July 10, 2020
Mon, 13 Jul 2020 17:16:34 +0530

Financial Video

Fund Performance

Portfolio Login

Forgot Password

What’s New

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but